BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23254592)

  • 1. Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia.
    Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Nakamura S
    J Hum Hypertens; 2013 Jul; 27(7):417-20. PubMed ID: 23254592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2012 Nov; 11():140. PubMed ID: 23150952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.
    Gorostidi M; Sarafidis PA; de la Sierra A; Segura J; de la Cruz JJ; Banegas JR; Ruilope LM;
    Am J Kidney Dis; 2013 Aug; 62(2):285-94. PubMed ID: 23689071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment.
    Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ
    Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].
    Villeneuve F; Rosenbaum D; Gury C; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):198-202. PubMed ID: 22677179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study.
    Fernandez Fresnedo G; Franco Esteve A; Gómez Huertas E; Cabello Chaves V; Díz Gómez JM; Osorio Moratalla JM; Gallego Samper R; Gallego Valcárcel E; Campistol Plana JM; Marín Iranzo R; Arias Rodríguez M;
    Transplant Proc; 2012 Nov; 44(9):2601-2. PubMed ID: 23146468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension.
    Kawano Y; Minami J; Takishita S; Omae T
    Am J Hypertens; 1998 Oct; 11(10):1141-6. PubMed ID: 9799029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in office and ambulatory control of hypertension.
    Banegas JR; Segura J; de la Sierra A; Gorostidi M; Rodríguez-Artalejo F; Sobrino J; de la Cruz JJ; Vinyoles E; del Rey RH; Graciani A; Ruilope LM;
    Am J Med; 2008 Dec; 121(12):1078-84. PubMed ID: 19028204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White coat effect in treated hypertensive patients: sex differences.
    Myers MG; Reeves RA
    J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM; Candrilli SD; Kanyongo G
    Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age on interdependence and hierarchy of cardiovascular risk factors in hypertensive patients.
    Vyssoulis G; Karpanou E; Adamopoulos D; Tzamou V; Stefanadis C; Vischer UM
    Am J Cardiol; 2011 Jul; 108(2):240-5. PubMed ID: 21571245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.